55 related articles for article (PubMed ID: 16224780)
1. Focused library design in GPCR projects on the example of 5-HT(2c) agonists: comparison of structure-based virtual screening with ligand-based search methods.
Bissantz C; Schalon C; Guba W; Stahl M
Proteins; 2005 Dec; 61(4):938-52. PubMed ID: 16224780
[TBL] [Abstract][Full Text] [Related]
2. An efficient multistep ligand-based virtual screening approach for GPR40 agonists.
Yao S; Lu T; Zhou Z; Liu H; Yuan H; Ran T; Lu S; Zhang Y; Ke Z; Xu J; Xiong X; Chen Y
Mol Divers; 2014 Feb; 18(1):183-93. PubMed ID: 24307222
[TBL] [Abstract][Full Text] [Related]
3. Combinatorial Consensus Scoring for Ligand-Based Virtual Fragment Screening: A Comparative Case Study for Serotonin 5-HT(3)A, Histamine H(1), and Histamine H(4) Receptors.
Schultes S; Kooistra AJ; Vischer HF; Nijmeijer S; Haaksma EE; Leurs R; de Esch IJ; de Graaf C
J Chem Inf Model; 2015 May; 55(5):1030-44. PubMed ID: 25815783
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive comparative assessment of 3D molecular similarity tools in ligand-based virtual screening.
Jiang Z; Xu J; Yan A; Wang L
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34151363
[TBL] [Abstract][Full Text] [Related]
5. Identification of free fatty acid receptor 2 agonists using virtual screening.
Fells JI; Ai X; Weinglass A; Feng W; Lei Y; Finley M; Hoveyda HR; Fraser GL; Machacek M
Bioorg Med Chem Lett; 2020 Nov; 30(21):127460. PubMed ID: 32755680
[TBL] [Abstract][Full Text] [Related]
6. Similar, or dissimilar, that is the question. How different are methods for comparison of compounds similarity?
Rajda K; Podlewska S
Comput Biol Chem; 2020 Oct; 88():107367. PubMed ID: 32956952
[TBL] [Abstract][Full Text] [Related]
7. [Network pharmacology study of Xiaoxuming Decoction based on vasodilatory and vasoconstrictory related GPCR targets].
Lu WD; Li L; Shen YJ; Zhou R; Yang R; Pang XC; Du GH
Zhongguo Zhong Yao Za Zhi; 2018 Dec; 43(23):4698-4708. PubMed ID: 30717561
[TBL] [Abstract][Full Text] [Related]
8. On the relevance of query definition in the performance of 3D ligand-based virtual screening.
Vázquez J; García R; Llinares P; Luque FJ; Herrero E
J Comput Aided Mol Des; 2024 Apr; 38(1):18. PubMed ID: 38573547
[TBL] [Abstract][Full Text] [Related]
9. Identification of Nonpeptide Oxytocin Receptor Ligands by Receptor-Ligand Fingerprint Similarity Search.
Weill N; Valencia C; Gioria S; Villa P; Hibert M; Rognan D
Mol Inform; 2011 Jun; 30(6-7):521-6. PubMed ID: 27467153
[No Abstract] [Full Text] [Related]
10. Advances in virtual screening.
Muegge I; Oloff S
Drug Discov Today Technol; 2006; 3(4):405-411. PubMed ID: 38620182
[TBL] [Abstract][Full Text] [Related]
11. Virtual Screening-Based Drug Development for the Treatment of Nervous System Diseases.
Li Q; Ma Z; Qin S; Zhao WJ
Curr Neuropharmacol; 2023; 21(12):2447-2464. PubMed ID: 36043797
[TBL] [Abstract][Full Text] [Related]
12. G protein-coupled receptors: structure- and function-based drug discovery.
Yang D; Zhou Q; Labroska V; Qin S; Darbalaei S; Wu Y; Yuliantie E; Xie L; Tao H; Cheng J; Liu Q; Zhao S; Shui W; Jiang Y; Wang MW
Signal Transduct Target Ther; 2021 Jan; 6(1):7. PubMed ID: 33414387
[TBL] [Abstract][Full Text] [Related]
13. Ligand discovery from a dopamine D3 receptor homology model and crystal structure.
Carlsson J; Coleman RG; Setola V; Irwin JJ; Fan H; Schlessinger A; Sali A; Roth BL; Shoichet BK
Nat Chem Biol; 2011 Sep; 7(11):769-78. PubMed ID: 21926995
[TBL] [Abstract][Full Text] [Related]
14. Using ligand-based virtual screening to allosterically stabilize the activated state of a GPCR.
Taylor CM; Rockweiler NB; Liu C; Rikimaru L; Tunemalm AK; Kisselev OG; Marshall GR
Chem Biol Drug Des; 2010 Mar; 75(3):325-32. PubMed ID: 20659113
[TBL] [Abstract][Full Text] [Related]
15. Understanding functional residues of the cannabinoid CB1.
Shim JY
Curr Top Med Chem; 2010; 10(8):779-98. PubMed ID: 20370713
[TBL] [Abstract][Full Text] [Related]
16. Toward the discovery of vaccine adjuvants: coupling in silico screening and in vitro analysis of antagonist binding to human and mouse CCR4 receptors.
Davies MN; Bayry J; Tchilian EZ; Vani J; Shaila MS; Forbes EK; Draper SJ; Beverley PC; Tough DF; Flower DR
PLoS One; 2009 Nov; 4(11):e8084. PubMed ID: 20011659
[TBL] [Abstract][Full Text] [Related]
17. Identifying conformational changes of the beta(2) adrenoceptor that enable accurate prediction of ligand/receptor interactions and screening for GPCR modulators.
Reynolds KA; Katritch V; Abagyan R
J Comput Aided Mol Des; 2009 May; 23(5):273-88. PubMed ID: 19148767
[TBL] [Abstract][Full Text] [Related]
18. Modulating G-protein coupled receptor/G-protein signal transduction by small molecules suggested by virtual screening.
Taylor CM; Barda Y; Kisselev OG; Marshall GR
J Med Chem; 2008 Sep; 51(17):5297-303. PubMed ID: 18707087
[TBL] [Abstract][Full Text] [Related]
19. Ligand and structure-based methodologies for the prediction of the activity of G protein-coupled receptor ligands.
Costanzi S; Tikhonova IG; Harden TK; Jacobson KA
J Comput Aided Mol Des; 2009 Nov; 23(11):747-54. PubMed ID: 18483766
[TBL] [Abstract][Full Text] [Related]
20. On the applicability of GPCR homology models to computer-aided drug discovery: a comparison between in silico and crystal structures of the beta2-adrenergic receptor.
Costanzi S
J Med Chem; 2008 May; 51(10):2907-14. PubMed ID: 18442228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
